Detection of malignancy markers in thyroid nodules by reverse transcriptase polymerase chain reaction (RT-PCR);Detección de marcadores de malignidad en nódulos tiroideos por transcripción reversa y reacción en cadena de la polimerasa (RT-PCR)

Revista Medica de Chile

Volumn 131, Issue 9, 2003, Pages 965-972

  Pineda B, Pedro ^a,b   Rojas G, Paula ^a   Liberman G, Claudio ^a   Moyano S, Leonor ^a   Goecke S, Irmgadt ^b  

^a UNIVERSITY OF CHILE   (Chile)

^b HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

Author keywords

Biopsy needle; Reverse transcriptase polymerase chain reaction; Thyroid neoplasms; Thyroid nodule

Indexed keywords

BIOLOGICAL MARKER; DIPEPTIDYL PEPTIDASE IV; GALECTIN 3; MESSENGER RNA; MUCIN 1; THYROTROPIN RECEPTOR; TUMOR MARKER;

ARTICLE; ASPIRATION BIOPSY; CANCER DIAGNOSIS; CLINICAL ARTICLE; CORRELATION ANALYSIS; CYTOLOGY; DIAGNOSTIC PROCEDURE; HUMAN; HUMAN TISSUE; PAPILLARY CARCINOMA; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID GLAND; THYROID NODULE; TUMOR CELL; AGAR GEL ELECTROPHORESIS; CHEMISTRY; METHODOLOGY; NEEDLE BIOPSY; PROSPECTIVE STUDY;

BIOPSY, FINE-NEEDLE; CARCINOMA, PAPILLARY; ELECTROPHORESIS, AGAR GEL; HUMANS; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THYROID NODULE; TUMOR MARKERS, BIOLOGICAL;

EID: 1542710815     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. TUNBRIDGE WM, EVERED DC, HALL R, APPLETON D, BREWIS M, CLARK F ET AL. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 1977; 7: 481-93.
2. VANDER JB, GASTON EA, DAWBER TR. The significance of nontoxic thyroid nodules. Final report of a 15 years study of the incidence of thyroid malignancy. Ann Intern Med 1968; 69: 537-40.
3. BRANDER A, VIIKINKOSKI P, NICKELS J, KIVISAARI L. Thyroid gland: US screening in a random adult population. Radiology 1991; 181: 683-7.
4. EZZAT S, SARTI DA, CAIN DR, BRAUNSTEIN GD. Thyroid incidentalomas. Prevalence by palpation and ultrasonography. Arch Intern Med 1994; 154: 1838-40.
5. RIDGWAY C. Clinical evaluation of solitary thyroid nodules. En: Braverman L and Utiger R, ed. The Thyroid: a fundamental and clinical text. Philadelphia: Editorial Lippincott Williams & Wilkins, 2000; 949-56.
6. MAZZAFERRI EL. Management of a solitary thyroid nodule. N Engl J Med 1993; 328: 553-9.
7. BHATTACHARYYA N, FRIED MP. Assessment of the morbidity and complications of total thyroidectomy. Arch Otolaryngol Head Neck Surg 2002; 128: 389-92.
8. PIRAINO P, IBARRA A, ARROYO A, PUMARINO H, BARSBY F. Punción tiroidea y citología tiroidea; correlación citohistológica en 136 pacientes operados de bocio nodular. Rev Méd Chile 1992; 120: 886-92.
9. LA ROSA GL, BELFIORE A, GIUFFRIDA D, SICURELLA C, IPPOLITO O, RUSSO G ET AL. Evaluation of the fine needle aspiration biopsy in the preoperative selection of cold thyroid nodules. Cancer 1991; 67: 2137-41.
10. GHARIB H, GOELLNER JR. Fine needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med 1993; 118: 282-9.
11. GHARIB H, GOELLNER JR, ZINSMEISTER AR, GRANT CS, VAN HEERDEN JA. Fine needle biopsy of the thyroid. The problem of suspicious findings. Ann Intern Med 1984; 101: 25-8.
12. SCHLINKERT RT, VAN HEERDEN JA, GOELLNER JR, GHARIB H, SMITH SL, ROSALES RF ET AL. Factors that predict malignant thyroid lesions when fine needle aspiration is "suspicious for follicular neoplasm". Mayo Clin Proc 1997; 72: 913-6.
13. TANAKA K, INOUE H, MIKI H, MASUDA E, KITAICHI M, KOMAKI K ET AL. Relationship between prognostic score and thyrotropin receptor (TSH-R) in papillary thyroid carcinoma: immunohistochemical detection of TSH-R. Br J Cancer 1997; 76: 594-9.
14. ORLANDI F, SAGGIORATO E, PIVANO G, PULIGHEDDU B, TERMINE A, CAPPIA S ET AL. Galectin-3 is a presurgical marker of human thyroid carcinoma. Cancer Res 1998; 58: 3015-20.
15. TAKANO T, MATSUZUKA F, SUMIZAKI H, KUMA K, AMINO N. Rapid detection of specific messenger RNAs in thyroid carcinomas by reverse transcription-PCR with degenerates primers: specific expression of oncofetal fibronectin messenger RNA in papillary carcinoma. Cancer Res 1997; 57: 3792-7.
16. WINZER R, SCHMUTZLER C, JAKOBS TC, EBERT R, RENDI. J, REINERS C ET AL. Reverse transcriptase-polymerase chain reaction analysis of thyrocyte relevant genes in fine needle aspiration biopsies of the human thyroid. Thyroid 1998; 8: 981-7.
17. TAKANO T, MIYAUCHI A, MATSUZUKA F, LIU G, HIGASHIYAMA T, YOKOZAWA T ET AL. Preoperative diagnosis of medullary thyroid carcinoma by RT-PCR using RNA extracted from leftover cells within a needle used for fine needle aspiration biopsy. J Clin Endocrinol Metab 1999; 84: 951-5.
18. TAKANO T, MIYAUCHI A, MATSUZUKA F, KUMA K, AMINO N. Expression of oncofetal fibronectin messenger ribonucleic acid in fibroblasts in the thyroid: A possible cause of false positive results in molecular based diagnosis of thyroid carcinomas. J Clin Endocrinol Metab 2000; 85: 765-8.
19. MASSON D, DENIS MG, LUSTENBERGER P. Limitations of CD44v6 amplification for the detection of tumour cells in the blood of colorectal cancer patients. Br J Cancer 2000; 82: 1283-9.
20. WEISS M, BARUCH A, KEYDAR I, WRESCHNER DH. Preoperative diagnosis of thyroid papillary carcinoma by reverse transcriptase polymerase chain reaction of the MUC 1 gene. Int J Cancer 1996; 66: 55-9.
21. TANAKA T, UMEKI K, YAMAMOTO I, SAKAMOTO F, NOGUCHI S, OHTAKI S. CD26 (dipeptidyl peptidase IV/DPP IV) as a novel molecular marker for differentiated thyroid carcinoma. Int J Cancer 1995; 64: 326-31.
22. GASBARRI A, MARTEGANI MP, DEL PRETE F, LUCANTE T, NATALI PG, BARTOLAZZI A. Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules. J Clin Oncol 1999; 17: 3494-502.
23. TAKANO T, MIYAUCHI A, YOKOZAWA T, MATSUZUKA F, LIU G, HIGASHIYAMA T ET AL. Accurate and objective preoperative diagnosis of thyroid papillary carcinomas by reverse transcription-PCR detection of oncofetal fibronectin messenger RNA in fine needle aspiration biopsies. Cancer Res 1998; 58: 4913-7.
24. CHEUNG CC, CARYDIS B, EZZAT S, BEDARD YC, ASA SL. Analysis of ret/PTC gene rearrangements refines the fine needle aspiration diagnosis of thyroid cancer. J Clin Endocrinol Metab 2001; 86: 2187-90.
25. HAUGEN BR, WOODMANSEE WW, MCDERMOTT MT. Towards improving the utility of fine needle aspiration biopsy for the diagnosis of thyroid tumors. Clin Endocrinol (Oxf) 2002; 56: 281-90.
26. LIOU MJ, CHAN EC, LIN JD, LIU FH, CHAO TC. Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms. Cancer Lett 2003; 191: 223-7.
27. COHEN Y, XING M, MAMBO E, GUO Z, WU G, TRINK B ET AL. BRAF mutation in papillary thyroid carcinoma. J Natl Cancer Inst 2003; 95: 625-7.
28. MARTINS L, MATSUO SE, EBINA KN, KULCSAR MA, FRIGUGLIETTI CU, KIMURA ET. Galectin-3 messenger ribonucleic acid and protein are expressed in benign thyroid tumors. J Clin Endocrinol Metab 2002; 87: 4806-10.
29. NIEDZIELA M, MACELUCH J, KORMAN E. Galectin-3 is not an universal marker of malignancy in thyroid nodular disease in children and adolescents. J Clin Endocrinol Metab 2002; 87: 4792-6.
30. BELFIORE A, LA ROSA GL. Assessment of thyroid function and disease. Fine needle aspiration biopsy of the thyroid. Endocrinol Clin North Am 2001; 30: 361-400.
31. THE PAPANICOLAOU SOCIETY OF CYTOPATHOLOGY TASK FORCE ON STANDARDS OF PRACTICE. Guidelines of the Papanicolaou society of cytopathology for the examination of fine needle aspiration specimens from thyroid nodules. Mod Pathol 1996; 9: 710-5.
32. CARBONE A, GLOGHINI A, ZAGONEL V, ALDINUCCI D, GATTEI V, DEGAN M ET AL. The expression of CD26 and CD40 ligand is mutually exclusive in human T-cell non Hodgkin's lymphomas/leukemias. Blood 1995; 86: 4617-26.
33. IWATA S, MORIMOTO C. CD26/dipeptyl peptidase IV in context: the different roles of a multifunctional ectoenzime in malignant transformation. J Exp Med 1999; 190: 301-5.
34. ARATAKE Y, UMEKI K, KIYOYAMA K, HINOURA Y, SATO S, OHNO A ET AL. Diagnostic utility of galectin-3 and CD20/DPPIV as preoperative diagnostic markers for thyroid nodules. Diagn Cytopathol 2002; 26: 366-72.
35. BARTOLAZZI A, GASBARRI A, PAPOTTI M, BUSSOLATI G, LUCANTE T, KHAN A ET AL. Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet 2001; 1644-50.
36. SAGGIORATO E, CAPPIA S, DE GIULI P, MUSSA A, PANCANI G, CARACI P ET AL. Galectin-3 as a presurgical immunocytodiagnostic marker of minimally invasive follicular thyroid carcinoma. J Clin Endocrinol Metab 2001; 86: 5152-8.
37. GENDLER SJ, LANCASTER CA, TAYLOR-PAPADIMITRIOU J. DUHIG T, PEAT N, BURCHELL, J ET AL. Molecular cloning and expression of human tumor associated polymorphic epitelial mucin. J Biol Chem 1990; 265: 15286-93.
38. RUBIN JS, BLOOR BK, HART IR, MORGAN PR. MUC-1 gene expression in head and neck squamous cell carcinomas. J Laryngol Otol 2000; 114: 772-6.
39. MONGES GM, MATHOULIN-PORTIER MP, ACRES RB, HOUVENAEGHEL GF, GIOVANNINI MF, SEITZ JF ET AL. Differential MUC 1 expression in normal and neoplastic human pancreatic tissue. An immunohistochemical study of 60 samples. Am J Clin Pathol 1999; 112: 635-40.
40. BIECHE I, RUFFET E, ZWEIBAUM A, VILDE F, LIDEREAU R, FRANC B. MUC1 mucin gene, transcripts, and protein in adenomas and papillary carcinomas of the thyroid. Thyroid 1999; 7: 725-31.
41. LIND P, LANGSTEGER W, MOLNAR M, GALLOWITSCH HJ, MIKOSCH P, GÓMEZ I. Epidemiology of thyroid diseases in iodine sufficiency. Thyroid 1998; 8: 1179-83.
42. NIKIFOROVA MN, BIDDINGER PW, CAUDILI CM, KROLL TG, NIKIFOROV YE. PAX8-PPARχ rearrangement in thyroid tumors. RT-PCR and immunohistochemical analyses. Am J Surg Pathol 2002; 26: 1016-23.
43. CHEUNG L, MESSINA M, GILL A, CLARKSON A, LEAROYD D, DELBRIDGE L ET AL. Detection of the PAX8-PPARχ fusion oncogene in both follicular thyroid carcinomas and adenomas. J Clin Endocrinol Metab 2003; 88: 354-7.